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Lead toxicity is a major public health problem in the
United States. Recent statistics indicate that in the
United States, between 3 and 4 million children ages
6 months to5 years andapproximately 400,000 infants
in utero are exposed each year to lead in quantities
associated with blood lead concentrations in excess of
15 g/dL whole blood. Blood lead concentrations chiefly
reflect recent lead exposures. Lead is accumulated in
the human skeleton, which is generally thought to
provide an indicator ofbody burden of lead.
Previous information based on chemical analyses of
skeletal tissues indicate that among adults, over 95%
oflead is in the skeleton. For children, approximately
70% of total body lead is present in osseous tissues.
Since it is rarely possible to analyze either the total
skeleton, or even an entire bone, biopsy techniques
have been developed. Biopsies usually are accom-
plished by removing a small sample ofbone (for exam-
ple, several hundredmilligrams)fromthe skeleton and
conducting chemical analyses for the material of in-
terest, e.g., lead. A major question about biopsies is
whether or not the sample taken is representative of
the entire bone or skeleton. Techniques for measure-
ment oflead in vivo have been developed to replace the
invasive procedures used in bone biopsy and yet pro-
vide a measure ofthis body lead pool.
Data on chemical measurements oflead inthe skele-
ton based on analyses ofsamples from the tibia, skull,
ileum, vertebra, and rib have been used to estimate
total skeletal lead for specific age and sex groups.
Methods have been developed to estimate skeletal bur-
den oflead from selected bones for persons ofspecified
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age and sex groups. During periods ofrapid growth or
changes in bone metabolism (e.g., chemical matura-
tionofthe skeleton), the abilitytopredict skeletal lead
from a single bone is reduced. In general, the macro-
distribution of some elements of interest within the
total skeleton is not readily available.
Bone physiology is complex, and specific types of
bone have different rates of growth and mineraliza-
tion, as well as final density. Normal bone growth pro-
ceeds in a predictable manner in which cartilaginous
matrix is converted to mineralized cartilage and layer
to mature, well-calcified bone. Recent studies pre-
sented at this conference emphasized newer areas re-
garding the role of cation-binding proteins that are
part of the organic matrix. These proteins have age-
specific distributions that differ by bone type and age
ofthe subject. For example, some ofthese proteins are
present only amongveryyounganimals. These cation-
ic proteins also occur in nonosseous tissues.
The process by which bone is formed and resorbed is
controlledby a number ofendocrine andmetabolicfac-
tors. Thereappeartobe anumberofcellulartargetsfor
lead. Recent studies have specifically examined lead
interference with calcium metabolism in osseous tis-
sue with emphasis on endocrine and cellular (e.g., sec-
ondmessenger)alterations. There are nowanumberof
cellular systems for studying bone resorption and ef-
fects of lead on subcellular metabolic processes.
Lead present in any particular tissue compartment
represents a combination of current environmental
lead exposure and internal sources of lead. Although
bone is generally regarded as a major storage site for
lead, under conditions of either reduced external ex-
posure to lead or bone demineralization, bone can be-
come an internal source of lead. Other studies pre-
sented at this conference summarized information on
biokinetics oflead, notingthatturnover varies greatly
frombone tobone with age and sex ofthe subject. This
mobilization ofbone can greatly affect blood lead con-
centration. Skeletal turnover is highest among chil-
dren under 10 years ofage. Turnover declines to aboutNORDBERG ET AL.
2 to 4% among middle-aged adults and increases
among elderly females. Bone turnover is strongly in-
fluencedbyfactorsthatinclude nutritional status, age,
and pathological conditions such as osteoporosis.
Various techniques exist for measurement oftissue
leadconcentrations. However,nucleartechniqueshave
been developed that are applicable to in situ, in vivo
analysis of metals. There was extensive discussion of
fundamental design issues with regard to geometry
and radiation used in X-ray fluorescence with em-
phasis on efficiency ofexcitation, background scatter,
and penetration depth. The currently available meth-
odologies for in situ, in vivo analysis ofbone lead con-
centrations are based on L X-ray using an iodine-125
source and K X-ray using either cadmium-109 or co-
balt-57 sources. L X-ray and K X-ray techniques ana-
lyze only extremely superficial bones very near the
skin, such as tibia or calcaneus. Even among these
bones, the L X-ray is limited to extremely superficial
layers, measuringat mostthetop 1 or2 mmofbone de-
pendingonthelayerofskincovering. The K X-raypen-
etrates to a much greater depth, approximately 20 to
40 mm ofbone.
The distribution ofleadbetweenthe mostsuperficial
and deeper part of the cortex will be of immense im-
portance in interpreting the results ofbone the L and
K X-ray fluorescence analyses. Data presented by sev-
eral investigators demonstrated variations in concen-
trations of lead in specific bone regions. The L X-ray
and K X-ray are very likely detecting different pools of
lead within bone. For example, the L X-ray appears to
identify a peak ofleadjust under the top millimeter of
the periosteum. This peak appears to correspond to re-
cently deposited lead and correlate well with the
ethylene diamine tetraacetate (EDTA)-chelatable lead
pool. By contrast, the K X-ray method provides biopsy
ofa much larger sample ofbone lead. Whether or not
these methods sample pools ofleadthat have different
metabolic significance remains a research issue.
Conference participants shared their experiences




calcium). TheLX-raysystem, although itsamplesonly
a much smaller depth, expresses lead relative to an
area rather than on a bone mineral basis. Both meth-
ods offer advantages depending on the research ques-
tion. Under some circumstances, it may be useful to
measure lead based on surface area (e.g., rapidly
changing conditions ofexternal lead exposure), while
underotherconditionsexpressingleadcontentonly on
the basis ofbone mineral (e.g., osteoporosis) would pro-
vide more useful information.
The extent to which the skin and bone marrow in
children are exposed to radiation from these methods
has been assessed. The radiation dose was generally
consideredtobe less thanwholebody exposures to less
than adayofnatural earth radiation or, statedanother
way, a fraction ofthe radiation from a dental X-ray. It
shouldbenotedthatthesearedifficultcomparisonsbe-
cause the radiation estimates are to relatively broad
body surface areas, whereas this dose is focused on a
small area. Overall, however, the health physicists re-
garded the quantities ofradiation used by these tech-
niques as having very minor health significance.
Bone leadconcentration and its measurement quali-
ty are determined, inpart, by measurement variation,
exposure variation, and individual metabolic condi-
tions. There are a number ofdifferent approaches that
canbe usedto evaluate techniquesfor measurement of
lead inbone. The predominant issue atthis stage ofre-
search development is the extent to which these mea-
surements reflect overall bone lead pool. Bone lead is
a good indicator oflong-term lead absorption. Cortical
bone has an average half-time forleadofsome 10 to 20
years, while trabecular bone has approximately a 5-
year half-time.
Most ofthe experience in measurement ofbone lead
in vivoamongadultshasbeenconductedwiththe K X-
ray instrumentation. Efforts to evaluate the contribu-
tionofskeletal leadtobloodleadhavebeencarriedout
by several groupsofinvestigators among active andre-
tired lead workers. Among retired workers, a substan-
tial proportion oflead inblood(e.g., two-thirds) was re-
latedtopreviouslyaccumulated skeletal storesoflead.
Based on chemical analyses of lead concentrations
from vertebral biopsy samples ofbone, a good relation
wasobservedbetweenbloodleadandvertebral leadfor
both active and retired workers. Comparison of such
valueswith lead excretionbyprovocative EDTA chela-
tion tests indicated a lower correlation. However, the
leadpool removedby provocative EDTA chelation may
be representative of a biologically more active lead
pool.
The L X-ray system has been used to measure bone
lead among children. Instrumentation developed us-
ing the L X-ray system measures lead in the most
superficialportionofthebone. Thetechnique hasbeen
used for investigations ofchildren who required treat-
ment for lead toxicity. It is worthy of substantial at-
tention that after recommended medical treatment,
following guidelines from professional associations
and the Centers for Disease Control, that these chil-
dren had bone concentrations generally in excess of
adults having typical and occupational exposures to
lead. Lead produces chronic adverse effects on health
that makesthese highly elevatedbone leadconcentra-
tions in such young children particularly dangerous.
Using the X-ray methodology, the actual depth of
bone mineral measured is highly dependent upon the
thickness of soft tissue (e.g., skin) covering the bone.
This method measures the most superficial layer of
bone mineral, immediately underthe periosteum. The
radiation dosetothe skin isapproximately 1/20ththat
ofa chest X-ray. The current detection limit ofthe L X-
ray methodhas a detection limit of7 Ag lead/g ofbone
with9.2% in vivoreproducibilityofthesemethods. One
ofthe major difficulties with application ofthe L X-ray
methodology isthatthe generalpopulationofchildren
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has bone lead concentrations lower than 7itg lead/g of
bone. A figure frequently cited for children is 5 jg
lead/g ofbone. Improvement inthe L X-ray methodolo-
gy couldbe achievedthrough columination ofthe elec-
tron beam to reduce background scatter; improved
beampolarization; more sensitive detectors; andalter-
native methods for statistical analysis of the signal.
Boththe LX-ray andK X-ray quantitative limits could
be improved by longer counting time or changing the
configuration ofthe detectors to capture energy emit-
ted from the bone. Longer counting times for in vivo
measurements may create problems because the lead
is expressed on the basis ofbone mineral. The K X-ray
has analytical sensitivity to approximately ±5jiglead/g
bone mineral.
The overall view ofthe conference participants was
that the L X-ray and K X-ray measure different frac-
tions ofbone lead, although the K andL X-rays maybe
compared on technical issues, such as quantitative
limits. It appears that L X-ray quantifies lead nearest
the periosteum, which may be associated closely with
lead accessible by provocative EDTA chelation (i.e., a
diagnostictechnique)reflectingrelatively morerecent
lead exposure than that identified in deeper bone lay-
ersbythe K X-raytechniques. The K X-ray methodolo-
gy samples a much larger area ofbone and appears to
be more reflective of chronic, cumulative exposure to
lead. The radiation dose wasgenerally notregarded as
substantial issue for either ofthese techniques.
Advances inbeing able to measure bone lead in vivo
are advantageous indiagnosisofleadtoxicity. Another
use of in vivo measurement ofbone lead is to develop
improved methods to be used in screening or epidemi-
ological studies that assess potential association of
body lead burden with adverse health effects. Current
research onleadandhealth indicate subtle but signifi-
cant neurobehavioral and cognitive dysfunction at
lead exposures present in approximately 40 to 50% of
the general population ofyoung children. These criti-
cal effects are considered to be associated with lead in
nonosseoustissues, e.g., thecentral nervous system. To
date, lead exposures associated with these effects have
been referenced to blood lead concentrations and, in
some instances, todentine leadconcentrations andthe
indices of internal exposure.
Boneanddentine leadareindicatorsofanintegrated
soft tissue dose of lead over time. Bone lead concen-
trations have been associated with blood lead con-
centrations, however, typically at higher blood lead
quantities, e.g., > 20Ag lead/dL whole blood. Numer-
ous strategies exist to improve the count rate (i.e., cap-
ture offluorescence emitted from the bone or capture
ofemittedradiation fromthebone)without increasing
radiation ofthe bone or increasing counting time.
A number of physiological and pathological condi-
tions can alter the distribution of lead between bone
andnonosseoustissues. These include age, nutritional
and endocrine status ofthe subject, pregnancy, lacta-
tion, osteoporosis, and renal disease. Children have a
far higher rate ofskeletal turnover and remodeling of
bone, resulting in a potentially larger pool ofbiologi-
cally active lead. Pregnancy and lactation represent
severe calcium stresses on the adult woman that are
typically accompaniedby mobilization ofskeletal min-
eral. Lead is mobilized along with bone mineral and
transferred across the placenta or is secreted in milk
during lactation.
A critical factor in designing effective methods for
measurement of bone lead concentrations is under-
standing the types of research questions that such
measurements can be used to answer. In our enthusi-
asmtobe able to measurebone lead in vivoand insitu,
it is critical not to lose sight ofthe fundamental recog-
nition that development ofbiological indicators ofthe
physiological active pool oflead remains an essential
consideration. Todatemostresearchonadverse effects
of lead have been referenced to blood lead concentra-
tion, whichdoes not estimate long-term leadexposure.
Lead accumulation in bone can become an internal
source of lead that may be particularly important in
development ofchronic disease. Both L X-ray and K X-
ray instrumentation potentially provide important
contributions to understanding the association be-
tween external lead dose, internal lead dose, and hu-
man health effects. Further research is also clearly
needed on the cellular and subcellular deposition of
lead inbone, since such data may provide useful inter-
pretation ofinformation about the biochemical active
lead pool in bone.
Effects of Lead on Target Organ
Systems
The second phase of the workshop examined the
known and potential consequences of lead mobiliza-
tion frombone on various target organ systems. There
arepublished clinical studiesthatindicatethat mobil-
izationofleadfromthematernal skeletonduringpreg-
nancy is associated with significant exposure to both
the mother and fetus. Clinical case studies suggest
that in some instances this mobilization maybe ofsuf-
ficient magnitude to acutely intoxicate both mother
and infant. At lower dose levels, skeletal mobilization
of lead may produce decreases in stature and behav-
ioral and cognitive function deficits in infants. Mea-
surements of maternal skeletal burdens of lead thus
have great potential for assessing risk in this critical
human population.
A similar set ofconcerns was expressed for geriatric
populations where demineralization ofthe skeleton is
alsoknownto occur aspartofthe agingprocess. Inpar-
ticular, post-menopausal women undergoing osteopo-
rotic changes are of special concern. Mobilization of
lifetime lead stores during the later stages oflife with
redistribution to softtissues such asthe brain andkid-
ney would have widespread societal and public health
implications.
The influence ofnutrition factors such as dietary in-
take of calcium and other essential minerals in both
lead absorption from the gastrointestinal tract and
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mobilization from skeleton was also extensively ex-
amined. It was concludedthat such dietary factors are
of clear importance in mediating the availability of
lead in vivo. The influence ofdiet at various life stages
is an area ofgreat potential significance inpreventing
or attenuating internal lead exposure.
Release of lead from bone stores as a function and
cause of renal disease was also examined in detail.
Renal osteodystrophy is a common complication of
chronic kidney disease. Lead incorporation into bone
and structure ofmetaphysis bone have not been found
to be altered in lead-intoxicated rats, but further stud-
ies in humans are needed. Statistical studies of lead,
blood pressure, and cardiovascular disease showed a
small but attributable risk associated with lead. Vari-
ousanalysessuggestedthat achange inthepopulation
meanbloodleadfrom25 to 10 ig/dLwouldreduce myo-
cardial infarctions by approximately 30,000/year and
the incidence of all cardiovascular disease in the
United States by several million.
The well-known elevated incidence of renal disease
in lead-exposed workers was examined in light of re-
cent mechanistic studies concerning the effects oflead
inthe kidney. The known and possible roles ofhigh-af-
finity renal lead-binding proteins (PbBP) which ap-
pear to play a central role in mediating the effects of
lead in renal proximal tubule cells ofrats at low dose
levels was extensively discussed. The renal PbBP in
rats was found to be a specific cleavage product of a2-
microglobulin, which facilitated the nuclear uptake of
lead and bound to renal chromatin. This molecule,
which is a member ofthe retinol-binding protein fami-
ly, was immunologically distinct from a chemically
similarprotein in ratbrain and washighly localized in
only certain nephrons and proximal tubule segments.
It was hypothesized that there are analogous lead re-
ceptor molecules inhumansthat actto determine indi-
vidual susceptibility to lead toxicity on the basis of
genetic expression. Such a finding would have a far-
reaching impact on delineation of highly sensitive
human populations at special risk for lead toxicity.
Strategies using new techniques for epidemiological
studies in known human populations at risk for lead
toxicity were discussed on the final day of the work-
shop. The special problems associated with elevated
lead exposure inpediatric populations received special
attention. Decrements in IQ at both ends ofthe intel-
ligence spectrum and delinquent behaviors associated
with lead may have important societal consequences.
There was a review of the potential utility of bone
leadmeasurements inexposedworkerpopulations and
the need for more thorough evaluations oflead effects
on target organs such as the kidney, immune, and re-
productive organ systems. The high incidence ofrenal
failure (2-6 times) among lead-exposed workers is of
particular concern since over 50% of end-stage renal
disease in the United States is of unknown etiology.
The critical need for the development of new and more
sensitive biological indicators oflead-exposure, effect,
and susceptibility in workers and the general popula-
tions was also discussed. Examples of such indicators
might include refinements (e.g., molecular biology) of
known approaches involving lead-induced distur-
bances of the heme biosynthetic pathway or develop-
ment of radioimmunoassays for specific excreted pro-
teinssuchastherenalPbBPthatappeartobe involved
in mediating the low-level effects oflead in target cell
populations ofthe nephron. There appeared to be gen-
eral agreement amongthe workshop participants that
development of such indicators coupled with the bet-
ter estimates ofinternal lead stores provided by X-ray
fluorescence analyses ofbone would provide the more
rigorous and sensitive analytical tools which will be
required to making risk assessments at low-level
exposures.
Summary Statements
The L X-ray andK X-ray appearto measure different
pools oflead in bone. It is not yet clear which ofthese
pools (or ifboth ofthese pools) is most clearly associ-
ated with recent lead exposures, with other parame-
tersofleadexposure (e.g., blood lead, EDTA chelatable
lead, or hemopoietic indicators of lead exposure), and
most importantly with disease outcome.
Distribution of lead between bone and nonosseous
tissues dependsonfactors including age, nutrition, en-
docrine status, gender, pregnancy, lactation, and path-
ological conditions including osteoporosis and renal
failure.
Use ofmethods to measure bone lead by either L X-
ray or K X-ray should be regarded as largely research
orclinical investigation techniques. Astheynow exist,
these techniques do not have current clinical applica-
tion other than clinical investigation. Several years of
refinement of methods are likely to be needed before
these techniques are broadly applicable.
Because current treatment methods oflead toxicity
do not adequately remove lead from bone (i.e., young
children after treatment may have bone lead concen-
trations similar to adults in the general and occupa-
tionally lead-exposed populations), lead remaining in
bone canbecome aninternal source ofleadandrelease
lead under adverse metabolic conditions.
Lead has a long half-life in bone: over 10 years for
many types ofbone. This can serve as a biomarker of
lead exposures that occurred many years earlier.
Mobilization of skeletal lead stores during preg-
nancy may expose both the mother and fetus to suffi-
cient quantities ofbiologically active lead to produce
both learning, behavioral deficits in the fetus. Mobi-
lization of skeletal lead in geriatric populations as a
result of osteoporosis or normal skeletal deminerali-
zationmayproduce deleterioustargetorgan systemef-
fects in latter stages of life.
Nutritional factors such as dietary calcium intake
appear to play important roles in mediating lead ab-
sorption form the gastrointestinal tract and mobiliza-
tion of lead from the skeleton.
Renal osteodystrophy is a common complication of
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renal failure that occurs at greater frequency in lead-
exposed workers.
Statistical analyses of lead blood pressure and car-
diovascular disease showed a small but attributable
risk associated with lead.
Studies inexperimental animals have demonstrated
the presence of lead-binding proteins in major target
organs such as the kidney and brain that appear to
share a number of characteristics with receptors for
other biologically active molecules. These molecules
may play a central role in delineating populations at
special risk for lead toxicity.
Lead has been shown to produce a number oflearn-
ing and behavioral deficits in humans that appear to
have a number ofserious societal consequences. Mea-
surements of lead in bone may greatly aid in assess-
ing behavioral deficits in humans by better defining
dosimetry.
More research is urgently needed to evaluate the ef-
fects of lead to relatively unstudied target organ sys-
tems for lead such as the kidney, immune, reproduc-
tive, and skeletal systems. There is a critical need for
new classes ofbiological indicators for assessing lead
exposure, lead effects, and susceptibility to leadtoxici-
ty at low exposure levels.
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